genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer
GEN Edge
Sangamo CEO Looks Long-Term toward In Vivo Genome Editing, Regulation
GEN Edge
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
GEN Edge
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
GEN Edge
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in…
News
News
Microfluidic Links between Organ Chips Break Preclinical Bottleneck
News
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
Neuroscience
Autism Symptoms Improved Using Prescription Drug that Changes Neurotransmitter Ratios
News
Natural Body Protein Found to Suppress Breast Cancer Metastasis
News
Fight-or-Flight Time? That’s When Calcium Channels Give Up Rad
Insights
All
Trends for 2020
Bioprocessing
Applying the Bioprocessing 4.0 Paradigm to Antibody Glycosylation
Bioprocessing
Working in Biopharma Globally
ALS
Neurodegenerative Treatments Build to a Tipping Point
Insights
Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures
A-Lists
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
CAR T-Cells
Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics
News
Microfluidic Links between Organ Chips Break Preclinical Bottleneck
News
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
Neuroscience
Autism Symptoms Improved Using Prescription Drug that Changes Neurotransmitter Ratios
Magazine
Artificial Intelligence
The Outlook for 2020 and Beyond
January 2020 Vol. 40 No. 1
Super-Resolution Microscopy Comes into Focus
January 2020 Vol. 40 No. 1
Biopharma’s Lab of the Future Can’t Wait
January 2020 Vol. 40 No. 1
Convergence Fends Off Malthus
January 2020 Vol. 40 No. 1
From CRISPR Multiplexing to Pleistocene Park
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Find the Right Fit when Tackling Late Stage Bioprocessing Challenges
Upcoming Webinars
Get Fired Up about Multiplexed Biomarker Profiling
On Demand Webinars
Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics
January 2020 Vol. 40 No. 1
Experimental Program Design Considerations for Optimized Use of Preclinical Models in…
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Tech Exclusives
Tech Exclusives
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Tech Exclusives
Forces Unite to Move Molecular Dx Out of the Gates
Tech Exclusives
Tea for Type 2: Green Tea Triggers Gene Editing System for Diabetes Treatment
Tech Exclusives
Genome Editing Heads to Primetime
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
Tech Exclusives
Blood Test to Diagnose Brain Cancer in Development
Tech Exclusives
Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Tech Exclusives
Beam Therapeutics Files for IPO, Pursuing Treatments Using Base Editing
Tech Exclusives
MicroRNA Biomarkers Make Melanoma Diagnosis More Objective
Tech Exclusives
Molecular Analysis of Elephantiasis Post-Treatment Adverse Events
Tech Exclusives
Long Reads and CRISPR Couple as Oxford Nanopore and Caribou Strike...
Tech Exclusives
Fungal-Derived Drugs Have Unexpected “Reaction”
Tech Exclusives
Continuous Manufacturing of Viral Vaccines
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; }
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
